Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biohaven Ltd. Common Shares (NY:BHVN)

13.75 +0.38 (+2.84%)
Official Closing Price Updated: 4:10 PM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biohaven Ltd. Common Shares

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
News headline image
Where Biohaven Pharma Hldgs Stands With Analysts ↗
Analysts have provided the following ratings for Biohaven Pharma Hldgs (NYSE:BHVN... 
Via Benzinga
2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)
Via AB Newswire
News headline image
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating... 
Via Benzinga
News headline image
Biohaven's Zavegepant Pain Spray Aces Late-Stage Migraine Trial ↗
Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) is eyeing filing for approval in early 2022 for its experimental pain spray after new data showed it hit its... 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Biohaven Pharma Hldgs ↗
Within the last quarter, Biohaven Pharma Hldgs (NYSE:BHVN) has observed the ... 
Via Benzinga
News headline image
Analyst Ratings For Biohaven Pharma Hldgs ↗
Within the last quarter, Biohaven Pharma Hldgs (NYSE:BHVN) has observed the f... 
Via Benzinga
News headline image
Where Biohaven Pharma Hldgs Stands With Analysts ↗
Within the last quarter, Biohaven Pharma Hldgs (NYSE:BHVN) has observed the ... 
Via Benzinga
News headline image
75 Biggest Movers From Yesterday ↗
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers... 
Via Benzinga
News headline image
Pfizer Gains Outside US Rights To Biohaven's Migraine Treatment For $500M ↗
Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) and Pfizer Inc (NYSE: PFE) have announced an agreement for rimegepant in markets outside the U.S.... 
Via Benzinga
News headline image
Why Biohaven Pharmaceuticals Stock Crumbled On This Premium Deal With Pfizer ↗
Biohaven will receive up to $1.24 billion in payments under a deal for Nurtec ODT. 
Via Investor's Business Daily
News headline image
58 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash. TDH... 
Via Benzinga
News headline image
Jim Cramer: MGM Resorts Has Good Top Management ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said MGM Resorts International (NYSE: MGM) has a lot of good top management. With Wynn Resorts, Limited (NASDAQ... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
News headline image
Cramer Likes American Eagle Outfitters And These 2 Pharma Stocks ↗
On CNBC’s “ 
Via Benzinga
News headline image
Where Biohaven Pharma Hldgs Stands With Analysts ↗
Analysts have provided the following ratings for Biohaven Pharma Hldgs (NYSE:BHV... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Wednesday ↗
Goldman Sachs lowered the price target on Nucor Corporation (NYSE: 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Biohaven Pharma Hldgs ↗
Biohaven Pharma Hldgs (NYSE:BHVN) has observed the following analyst ratings... 
Via Benzinga
News headline image
Biohaven Surges To Record High As Kardashian-Backed Migraine Drug Outperforms — Again ↗
This company sells a migraine medicine backed by Khloe Kardashian. 
Via Investor's Business Daily
News headline image
Why Are Biohaven Shares Trading Lower On Monday? ↗
Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) has announced results from a focused analysis of verdiperstat trial in verdiperstat in multiple system... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Syndax Pharmaceuticals (NASDAQ:SNDX) shares moved upwards by 8.94% to $20.48 during Monday's pre-market session. The company's market cap stands at $995.9... 
Via Benzinga
News headline image
Cramer Gives His Opinion On Service Corporation, Vertex And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't happy with the way Inseego Corp (NASDAQ: INSG) acts. He is beginning to believe it deserves to... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
News headline image
Cramer Gives His Opinion On Zillow, SoFi And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said this is a decent level at which to buy Zillow Group Inc Class A (NASDAQ: ZG) with mortgage rates so low.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... 
Via Benzinga
News headline image
Biohaven Pharma: Q2 Earnings Insights ↗
Shares of Biohaven Pharma Hldgs (NYSE:BHVN) rose 0.8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 2.75% year... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.